000 | 01097 a2200313 4500 | ||
---|---|---|---|
005 | 20250515054513.0 | ||
264 | 0 | _c20070402 | |
008 | 200704s 0 0 eng d | ||
022 | _a1367-6733 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMould, Diane R | |
245 | 0 | 0 |
_aThe pharmacokinetics and pharmacodynamics of monoclonal antibodies--mechanistic modeling applied to drug development. _h[electronic resource] |
260 |
_bCurrent opinion in drug discovery & development _cJan 2007 |
||
300 |
_a84-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aErbB Receptors _ximmunology |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Immunological |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
700 | 1 | _aSweeney, Kevin R D | |
773 | 0 |
_tCurrent opinion in drug discovery & development _gvol. 10 _gno. 1 _gp. 84-96 |
|
999 |
_c16826948 _d16826948 |